Overview

Carpal tunnel syndrome (CTS) is a chronic compression of the median nerve, which can lead to symptoms such as nocturnal pain and paresthesia in the area innervated by the median nerve. The affected patients also describe discomfort and hypoesthesia in the nerve supply area. Due to the COVID (Coronavirus disease) pandemic, CTS operations have been postponed and delayed. A promising and safe alternative for improving CTS-related symptoms appears to be non-invasive, non-thermal low-level-laser therapy. As a possible conservative, alternative method, low-level-laser therapy has the potential to enable patients with CTS to improve their disease-related symptoms or at least to alleviate the symptoms until the indicated CTS operation (carpal tunnel release).

The aim of this randomized, single-blind, placebo-controlled clinical trial is to investigate the influence of 3 weeks of low-level-laser therapy on the symptoms typical of CTS in patients with surgery-indicated carpal tunnel syndrome and its influence on quality of life.

Eligibility

Inclusion Criteria:

• Existing written consent of the participating person after informed consent.
• The patient is capable of giving consent.
• Isolated surgery-induced CTS
• CTS patients with pain (NRS between 2 and 6) and/or paresthesia and/or nocturnal pain that has been present for at least 3 months (pain reported using the "Numerical Rating Scale for Pain" (NRS) between 0 and 10).
• Compliance with 3 weeks of cold light therapy.

Exclusion Criteria:

• Absence of informed consent
• Patients under 18 years or over 80 years
• Patients from protected groups as well as people who are not able to personally give consent
• Participation in other clinical trials within the last 4 weeks before the start of the study
• traumatic and atraumatic median nerve lesions/damage/narrowing
• Previous operations in the area innervated by the median nerve or in the area of the affected upper extremity/hand
• CTS recurrence of the affected hand
• Thenar atrophy of the affected hand
• Nerve diseases that affect the upper extremity including the hand (e.g. polyneuropathy)
• Cervical radiculopathy C6/C
• Osteoarthritis of the affected hand (e.g. rhizarthrosis)
• Arthritis of the affected hand
• Metabolic diseases that have an influence on the sensory or function of the hand
• Vascular diseases affecting the upper extremity or hand (e.g. Raynaud's syndrome)
• other compressions or injuries of the median nerve (e.g. thoracic outlet syndrome, scalene syndrome, pronator teres syndrome)